Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes

Objective: Parkinson’s disease (PD) has significant clinical overlaps with atypical parkinsonism syndromes (APS), which have a poorer treatment response and a more aggressive course than PD. We aimed to identify plasma biomarkers to differentiate PD from APS. Methods: Plasma samples (n = 204) were o...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Chin-Hsien, Yang, Shieh-Yueh, Horng, Herng-Er, Yang, Che-Chuan, Chieh, Jen-Jie, Chen, Hsin-Hsien, Liu, Bing-Hsien, Chiu, Ming-Jang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934438/
https://www.ncbi.nlm.nih.gov/pubmed/29755341
http://dx.doi.org/10.3389/fnagi.2018.00123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934438/
https://www.ncbi.nlm.nih.gov/pubmed/29755341
http://dx.doi.org/10.3389/fnagi.2018.00123

Ejemplares similares